Journal details
MOLECULAR THERAPY NUCLEIC ACIDS
CELL PRESS · ISSN 2162-2531 · eISSN 2162-2531
SCIEScopusPMCDOAJ
Overview
MOLECULAR THERAPY NUCLEIC ACIDS. ISSN 2162-2531 · eISSN 2162-2531. published by CELL PRESS. United States. Medicine, Research & Experimental. impact factor 6.5 (2025). JCR Q1. CAS Zone 2 TOP. indexed in SCIE, Scopus, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 156 articles · 2025: 358 articles · 2024: 309 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR THERAPY NUCLEIC ACIDS?
The impact factor recorded for MOLECULAR THERAPY NUCLEIC ACIDS is 6.5 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR THERAPY NUCLEIC ACIDS?
MOLECULAR THERAPY NUCLEIC ACIDS is listed in CAS Zone 2 and marked as a TOP journal.
Which databases index MOLECULAR THERAPY NUCLEIC ACIDS?
MOLECULAR THERAPY NUCLEIC ACIDS is indexed in SCIE, Scopus, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.